Avanos Medical (AVNS) Gross Margin (2013 - 2026)

Avanos Medical has disclosed Gross Margin across 14 years of filings, most recently posting 51.7% for Q1 2026.

• Gross Margin for Q1 2026 came in at 51.7%, down 191.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 50.05% (down 455.0% YoY), and the FY2025 annual result was 50.47%, down 497.0% from the prior year.
• Gross Margin came in at 51.7% for Q1 2026 at Avanos Medical, up from 47.54% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 59.45% in Q2 2022 to a low of 47.54% in Q4 2025.
• The 5-year median for Gross Margin is 54.82% (2023), against an average of 54.68%.
• Peak annual rise in Gross Margin reached 1347 bps in 2022, while the deepest fall reached 3356 bps in 2022.
• Avanos Medical's Gross Margin stood at 56.66% in 2022, then fell by 3 bps to 54.82% in 2023, then retreated by 0 bps to 54.57% in 2024, then declined by 13 bps to 47.54% in 2025, then rose by 9 bps to 51.7% in 2026.
• The last three Gross Margin figures came in at 51.7% (Q1 2026), 47.54% (Q4 2025), and 48.37% (Q3 2025), per Business Quant data.